Skip to main content

Table 1 Statistical analysis of secondary outcomes

From: Oral epigallocatechin-3-gallate for treatment of dystrophic epidermolysis bullosa: a multicentre, randomized, crossover, double-blind, placebo-controlled clinical trial

Evolution of score (end of the period - beginning of the period)

Polyphenon E® Mean ± SD (N)

Placebo Mean ± SD (N)

p value

Surface area

- 4.07 ± 7.62 (12)

- 4.42 ± 9.84 (14)

0.93

Skin fragility

- 0.90 ± 2.46 (12)

- 0.64 ± 2.06 (14)

0.75

Mucosal involvement

0.55 ± 1.12 (8)

1.97 ± 1.64 (6)

0.07

Itch

- 1.17 ± 3.53 (12)

0 ± 2.16 (14)

0.38

Mean duration of wound healing (days)

-14.62 ± 18.76 (7)

1.78 ± 14.65 (9)

0.21

  1. N number of patients, SD standard deviation